Saba Capital Management’s Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 WRAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-175,686
Closed -$88K 783
2021
Q3
$88K Buy
+175,686
New +$89.1K ﹤0.01% 508

Other funds holding WRAC.WS

Saba Capital Management's WRAC.WS Position: Q4 2021 in Review

Saba Capital Management sold out of Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (WRAC.WS) in Q4 2021, closing a stake of 175,686 shares — an estimated $88K sold.

Saba Capital Management first reported a position in WRAC.WS in Q3 2021 and held it in 1 quarter. The position peaked at $88K in Q3 2021. 28 funds tracked by Wall St. Rank hold WRAC.WS as of Q4 2021.

  • Saba Capital Management reported no remaining Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Saba Capital Management sold 175,686 Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q4 2021, an estimated $88K.
  • Saba Capital Management first reported a position in Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 in Q3 2021 and held it in 1 quarter.
  • Saba Capital Management's Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $88K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 as of Q4 2021.

Based on Saba Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.